A retrospective, cohort study assessing safety and efficacy of ramucirumab in patient with unresectable hepatocellular carcinoma with prior treatment with tyrosine kinase inhibitor therapy
Latest Information Update: 25 May 2021
At a glance
- Drugs Ramucirumab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
Most Recent Events
- 25 May 2021 New trial record